DWJ 1355Alternative Names: DWJ1355
Latest Information Update: 22 Jan 2015
At a glance
- Originator Daewoong Pharmaceutical
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Thrombosis
Most Recent Events
- 22 Jan 2015 Early research in Thrombosis in South Korea (unspecified route) before January 2015